# A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.

> **NCT01285817** · PHASE2 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 79 (actual)

## Conditions studied

- Survival Without Progression

## Interventions

- **DRUG:** celecoxib, Vinblastine, Cyclophosphamide , methotrexate ,

## Key facts

- **NCT ID:** NCT01285817
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-12
- **Primary completion:** 2015-09-11
- **Final completion:** 2023-03-09
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01285817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01285817, "A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01285817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*